All News

Educate patients about how to purchase and store medical products without hoarding resources.

Many patients turn to fish oil supplements to gain the benefits of omega-3 fatty acids, but there are important considerations pharmacists should be aware of before recommending fish oil supplements to their customers.

Naxitamab-gqgk (Danyelza) is for the treatment of pediatric and adult patients with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow who have demonstrated a partial response, minor response, or stable disease to prior therapy.

Uristat helps to alleviate symptoms caused by urinary tract infection (UTI), including pain, burning, and needing to urinate urgently.

Ribociclib plus fulvestrant achieved a median overall survival of 67.6 months in the first line setting for postmenopausal women with HR-positive/HER2-negative advanced breast cancer.

Infections at community hospitals fell by 63% after 1 year and 77% after 3 years, new data show.

Individuals who have recovered from the initial disease are in generally poorer health later on compared with the general population, the analysis shows.

One of PQA's quantitative research projects that they are working on now is looking at how medication adherence is related to outcomes.

Asundexian was granted FDA Fast Track Designation based on a phase 2 study evaluating its safety and efficacy combined with antiplatelet therapy in patients following an acute, non-cardioembolic ischemic stroke.

Health care policy decisions based on sound data and research are essential for addressing the challenges.

Many of patients with hepatitis that pharmacists encounter have viral hepatitis, which can be easily remembered as the ABCs of hepatitis.

Health care and public health officials are concerned over the number of missed or declined immunizations, but the pharmacy can play a role in turning this tide.

Tirzepatide is a once-weekly glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist indicated as an adjunct to diet and exercise in adults with type 2 diabetes.

Atezolizumab (Tecentriq) is indicated for use in urothelial carcinoma, non-small cell lung cancer, triple-negative breast cancer, small cell lung cancer, hepatocellular carcinoma, and melanoma.

Dramamine Ginger Chews are designed for non-drowsy relief of multiple causes of nausea.

Investigators analyzed data from nearly 4000 individuals from the National Longitudinal Study of Adolescent to Adult Health.

The findings suggest that the broad use of race as a factor for providing certain health interventions and treatments should be reconsidered, investigators say.

Aklilu Tedla, vice president of strategy and business development at Cardinal Health, discusses the cell and gene therapies in the pipeline for approval by the FDA.

PQA's program is focused on quality measurement and improving the safe and appropriate use of medications.

Organizations should focus on improving employee well-being and reducing workplace stressors.

This week, Suzanne Soliman, PharmD, BCMAS, is joined by guests Joanna Catravas, PharmD, BCMTMS, and Lisa Scholz, PharmD, MBA, FACHE, to discuss nontraditional roles for pharmacists.

Studies have estimated that 16% of people with dementia experience depression, but this may be as high as 40%, demonstrating a great need for effective treatments.

With climate change potentially affecting pollen counts, new OTC products can relieve symptoms.

Aklilu Tedla, vice president of strategy and business development at Cardinal Health, discusses the future of pharmacies as more cell and gene therapy products become available to patients.

Scientific abstracts also address findings on cardiovascular disease and population, the connection between COVID-19 and HF, and links between prognosis and marital status.

The advisory, published in Circulation, is a call to action for a cultural shift to identify and remove barriers.

Individuals with type 2 diabetes who use insulin are often restricted when accessing continuous glucose monitoring systems.

Larger increases were typically seen in states with fewer deaths related to COVID-19, lower unemployment among women, analysis finds.

Long-term extension trial results show a consistent safety profile and durable efficacy for the treatment of adults with the skin condition.

Obeticholic acid (Ocaliva) is indicated for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA, or as monotherapy in adults unable to tolerate UDCA.